Меню Закрыть

Are adverse effects of cannabidiol CBD products caused by tetrahydrocannabinol THC contamination?

cannabidiol toxicity symptoms

This summary was produced by Emergency Care BC (formerly the BC Emergency Medicine Network) and uses the best available knowledge at the time of publication. However, healthcare professionals should continue to use their own judgment and take into consideration context, resources and other relevant factors. Emergency Care BC is not liable for any damages, claims, liabilities, costs or obligations arising from the use of this document including loss or damages arising from any claims made by a third party. Emergency Care BC also assumes no responsibility or liability for changes made to this document without its consent. This surge is likely due to the excitement behind potentially new medical breakthroughs and the desire as a culture to shift towards therapies that are more “natural.” However, most products, such as the one purchased by this patient are unregulated.

  • In 2011, Bergamaschi et al. reviewed CBD AEs in animals and humans, concluding that CBD is generally safe, but further research is needed to investigate in-depth the observed in vitro and in vivo AEs 57.
  • These authors suggested that research should pursue AEs of chronic administration, hormonal effects, enzyme inhibition or induction, genotoxicity, drug transporters, and interactions with other drugs.
  • The vast majority of severe adverse effects attributed to THC have been found in people using cannabis in the context of adult use, i.e. related to high doses of THC without medical monitoring.
  • It has to be pointed out though, that the in vitro studies used supraphysiological CBD concentrations.
  • Static beam performance, as an indicator of sensorimotor coordination, showed more footslips in the CBD group, but CBD treatment did not interfere with the animals’ speed and ability to complete the test.

Table 1. CBD adverse effects in preclinical studies.

  • Third, several aspects of a toxicological evaluation of a compound such as genotoxicity studies and research evaluating CBD effect on hormones are still scarce.
  • Exposure characteristics are generally related to excessive use in adults and inadvertent ingestions in small children.
  • The same value (10 mg CBD/day) was recently established by the Food Standards Agency in the UK as provisional acceptable daily intake (ADI) based on new data received from novel food applications41.
  • Contaminated CBD products can cause a range of health issues, from mild allergic reactions to more severe conditions like heavy metal poisoning or respiratory problems.

In contrast, phenobarbital, rifampicin, carbamazepine, and phenytoin induce CYP3A4, causing reduced CBD bioavailability.11 Approximately 60% of clinically prescribed drugs are metabolized via CYP3A4.1Table 1 shows an overview of the cytochrome inhibiting potential of CBD. It has to be pointed out though, that the in vitro studies used supraphysiological CBD concentrations. When Swiss mice received 30 mg/kg oral CBD or placebo in sunflower oil for 34 consecutive days, CBD decreased total circulating testosterone by 76% (still within normal ranges), significantly increased abnormalities in spermiation and meiotic stages 104. CBD-treated mice had a 38% reduction in spermatozoa in the epididymis tail and more head abnormalities in the sperm and cytoplasmic droplets in the flagella medial region. In 1981, Rosenkrantz and Hayden investigated acute cannabinoid toxicity in rhesus monkeys following 150, 200, 225, 250, or 300 mg/kg intravenous (IV) CBD for 9 days 61. Tremors were observed at all doses and CNS inhibition (depression, sedation, and prostration) was evident within 30 min.

Direct pharmacological effect of CBD as explanation of adverse effects

At that time, 32.6% of 12th-grade students reported ever using cannabis, 21.9% reported use in the preceding year, and 1.9% reported using on a daily basis. The decline in use was attributed to perceived risk and to personal disapproval of drugs. With chronic heavy smoking, users experience increased cough, sputum production, and wheezing. One study cites that the rate of decline of respiratory function in an 8-year period was greater among marijuana smokers than among tobacco smokers.

cannabidiol toxicity symptoms

Green Health Foundation

cannabidiol toxicity symptoms

Two previous reviews focused on the therapeutic effects but also included AEs. In 2011, Bergamaschi et al. reviewed CBD AEs in animals and humans, concluding that CBD is generally safe, but further research is needed is cbd addictive to investigate in-depth the observed in vitro and in vivo AEs 57. In 2017, Iffland and Grotenhermen confirmed CBD’s safety profile, especially compared to other antiepileptics and antipsychotics 58. These authors suggested that research should pursue AEs of chronic administration, hormonal effects, enzyme inhibition or induction, genotoxicity, drug transporters, and interactions with other drugs.

cannabidiol toxicity symptoms

Quality Of Evidence?

7Reports of abuse and toxicity are steadily growing, as the number of synthetic cannabinoids produced increases. Increasing varieties of synthetic cannabinoids have been synthesized over the last ten years to avoid classification as illegal agents by making chemical modifications to compounds. Despite known toxicity and increased availability of marijuana, many people continue to abuse synthetic cannabinoids for various reasons including lower cost as compared to marijuana and lack of detection on routine drug screening.

  • The World Health Organization (WHO) judged the compound as being well tolerated with a good safety profile3.
  • However, CBD toxicity at 1 µM was significantly impaired by caspase-inhibitors, poly(ADP-ribose) polymerase PARP-1 and calpain, suggesting caspase-dependent and -independent cell death pathway activation.
  • Cannabidiol may cause a slight decrease in blood pressure in some people when administered acutely in high doses (4).
  • Preclinical and clinical studies also report adverse effects (AEs) and toxicity following CBD intake.

Neurological and neuropsychiatric effects

  • With chronic heavy smoking, users experience increased cough, sputum production, and wheezing.
  • Among people who already have schizophrenia, cannabis use is predicted to worsen psychotic symptoms.
  • Research is still needed on larger cohorts of CBD patients, and evaluation of CBD effects following long-term exposure on genotoxicity and cytotoxicity, hormones, and the immune system are needed.
  • If these proposals could be confirmed within vivo data, consumers taking CBD orally could be exposed to such high ∆9-THC levels that the threshold for pharmacological action could be exceeded49.

If there is one area of medical practice with cannabinoids that raises most doubts for both… Meier, M. H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R. S., … Persistent cannabis users show neuropsychological decline from childhood to midlife—proceedings of the National Academy of Sciences, 109(40), E2657-E2664. This effect appears to be dose-dependent and may be exacerbated by the interaction with other hepatotoxic drugs.

Cerebral Aneurysm: Diagnosis and Treatment

cannabidiol toxicity symptoms

Peak urinary CBD and its metabolite concentrations occurred after 6 h in the low CBD group and after 4 h in the high CBD group. No effect was evident for urinary CBD and metabolite excretion except at the higher fentanyl dose, in which CBD clearance was reduced. Importantly, fentanyl coadministration did not produce respiratory depression or cardiovascular complications during the test sessions and CBD did not potentiate fentanyl’s effects. This paragraph describes CBD interaction with general (drug)-metabolizing enzymes, such as those belonging to the cytochrome P450 family. This might have an effect for coadministration of CBD with other drugs.7 For instance, CBD is metabolized, among others, via the CYP3A4 enzyme. Various drugs such as ketoconazol, itraconazol, ritonavir, and clarithromycin inhibit this enzyme.11 This leads to slower CBD degradation and can consequently lead to higher CBD doses that are longer pharmaceutically active.

Cannabinoid (Marijuana) Toxicity

These symptoms, patients report, may improve temporarily with repeated hot showers. Teacher of various medical cannabis diploma courses and certifications in Colombia, Ecuador, Mexico, Brazil and the USA. The number of replicates depended on several factors, sometimes restricted by the very low sample volume we amphetamine addiction treatment have received.

Both systems used the same type of separation column (Luna Omega Polar C18, 150 × 2.1 mm, 1.6 μm, 100 Å, Phenomenex, Aschaffenburg, Germany). The separation was isocratic with 25 % water (0.1 % formic acid) and 75 % acetonitrile (0.1 % formic acid) and a flow of 0.3 mL/min. In case of QTOF with 35 % water (0.1 % formic acid) and 65 % acetonitrile (0.1 % formic acid) and a flow of 0.45 mL/min. The evaluation took place after fragmentation of the mother ion into three mass traces for each compound.

cannabidiol toxicity symptoms

Genetic Factors Influencing CBD Metabolism

A healthy lifestyle may enhance the benefits of CBD and reduce the likelihood of adverse effects. However, like any substance, CBD can have side effects and pose certain risks. This article explores the side effects and toxicity of CBD, offering an in-depth look at what you need to know before taking CBD. Connect with healthcare professionals around the globe to get the most up-to-date medical cannabis information. Although rare, some cases have reported cardiovascular symptoms such as tachycardia and hypotension.